7:10AM Amyris Scientists describe breakthrough in development of anti-malarial drug precursor; Sanofi (SNY) utilizing Amyris engineered yeast strains to produce drug ingredient at scale (AMRS) 2.87 : Scientists from Amyris published in the journal Nature the details of a major breakthrough in the field of synthetic biology that allows for the production of a key precursor to Artemisinin, the key ingredient in the world's most effective and preferred drug in combating malaria. Earlier today, Sanofi (SNY) announced the launch of large-scale industrial production of Artemisinin utilizing Amyris designed strains.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.